Jinxin Fertility Group Limited (“JXR”) filed a Next Day Disclosure Return (28 April 2026) outlining recent share repurchase activities and the current share capital position.

Key takeaways

1. Latest on-market repurchase (28 April 2026) • Volume: 2,066,000 ordinary shares • Price range: HK$2.38–HK$2.42 • Consideration: HK$4.96 million • Shares will be cancelled; none were retained as treasury stock.

2. Cumulative repurchases pending cancellation (27 March–28 April 2026) • Total shares: 17,666,000 • Equivalent to 0.66 % of the 2,705,044,043 issued shares outstanding before the first transaction in the period. • Aggregate consideration (based on disclosed volume-weighted prices): approximately HK$42.27 million, implying an average cost of about HK$2.39 per share.

3. Share capital position • Issued shares outstanding (excluding treasury shares) stood unmoved at 2,705,044,043 as of both 21 April and 28 April 2026. • All 17.67 million repurchased shares remain in issued share capital until formal cancellation, after which the share count will contract by roughly 0.65 %.

4. Repurchase mandate utilisation • Authority granted: 26 June 2025 to buy back up to 274.47 million shares. • Shares already repurchased under the mandate: 57.33 million, representing 2.09 % of the share base on the mandate date. • Remaining headroom: about 217.14 million shares.

5. Post-repurchase restrictions In line with Hong Kong Listing Rules, JXR is subject to a moratorium on issuing new shares until 28 May 2026.

The company confirmed that all repurchases complied with Exchange regulations and that no material changes have been made to the June 2025 explanatory statement filed with the Hong Kong Stock Exchange.